CooperSurgical has acquired ZyMōt Fertility, a subsidiary of DxNow, Inc. Read the full announcement here.
Find out about the great work we have been undertaking in PGT-A, the features and benefits of this type of testing, our PGTai technology platform results and our upgrade PGTai 2.0 which is available in US labs from September 2019.
Senior Director, Clinical Strategy and Market Development, CooperSurgical
A Conversation with Clinical Science Specialist, Chelsea Woody In this interview, CooperSurgical’s Chelsea Woody, who specializes in genomics within Reproductive…
Alyssa Jones, ASRM 2023 In her presentation titled “Compelling Rationale for Integrating PGT-CompleteSM into your PGT Testing Protocol,” Facility Manager and Embryologist, Alyssa*…
CooperSurgical and NYU Langone Fertility Center Announce Study Data Showing Significant Increase in Ongoing Pregnancy and Live Birth Rates with…
Sperm preparation made easy ZyMōt™ represents a fundamental change in thinking about how to effectively separate high-quality sperm1 for ART…
Providing a new opportunity for patients in need Based on the long-established and clinically proven SAGE 1-Step medium, SAGE 1-Step…
Pipettes for manipulation and transfer of cumulus-oocyte complexes (COCs), oocytes, embryos and biopsy samples The Stripper™ and EZ-Range™ denuding and…
We think cryo billing, so you can think patient care Embryo OptionsSM is a digital cryopreservation billing and management platform…
We’d love to hear from you. How can we help?
